Ziel
The aim of TINN2 is to evaluate azithromycin, included in the EMEA priority list of the therapeutic areas that need specific drug evaluation in preterm and term neonates. Azithromycin is a macrolid antibiotic with anti-inflammatory properties active against Ureaplasma. It might be effective in reducing the severity of bronhopulmonary disease in which Ureaplasma infection and inflammation play a role. TINN2 involves European leaders in neonatology, paediatric pharmacology, methodology and SMEs that will establish links with ethical bodies and regulatory authorities. The programme will perform in silico experiments and evaluate formulations for neonates. The randomized placebo-controlled trial will be optimized using age-appropriate state-of-the-art methods adapted to neonates (including in silico experiments, pharmacokinetics and pharmacogenetics) to validate the components of a Paediatric Investigation Plan. It will be performed by neonatologists trained in paediatric pharmacology and clinical research in line with guidelines on Good Clinical Practice. All the ethical issues will be considered, including pain and distress, blood sampling (number and volume) and informed consent. Parent information sheets and consent form will be submitted to parents’ associations for approval. TINN2 will include short term safety and potential for long term adverse reactions. Results will be reported in order to allow a PUMA application and to improve neonatal care. Therefore, TINN2 will validate the appropriate use of azithromycin in neonates which will be of direct benefit to children, their families and health professionals. TINN2 will strengthen paediatric drug evaluation across Europe, support recent initiatives from the European pharmaceutical industry and build up a network of units with experience in clinical research that will be used for additional drug evaluation in neonates.
Wissenschaftliches Gebiet
Programm/Programme
Aufforderung zur Vorschlagseinreichung
FP7-HEALTH-2010-single-stage
Andere Projekte für diesen Aufruf anzeigen
Finanzierungsplan
CP-FP - Small or medium-scale focused research projectKoordinator
75654 Paris
Frankreich
Auf der Karte ansehen
Beteiligte (15)
75015 PARIS
Auf der Karte ansehen
L69 7ZX Liverpool
Auf der Karte ansehen
CF24 0DE Cardiff
Auf der Karte ansehen
NG7 2RD Nottingham
Auf der Karte ansehen
3015 GD Rotterdam
Auf der Karte ansehen
40225 Dusseldorf
Auf der Karte ansehen
75012 Paris
Auf der Karte ansehen
20156 Milano
Auf der Karte ansehen
L-2250 LUXEMBOURG
Auf der Karte ansehen
EC2Y 5EB London
Auf der Karte ansehen
75005 Paris
Auf der Karte ansehen
89081 Ulm
Auf der Karte ansehen
17177 Stockholm
Auf der Karte ansehen
4000 LIEGE
Auf der Karte ansehen
1085 Budapest
Auf der Karte ansehen